AYJ

Valneva SE

DE Healthcare Biotechnology

Latest week
10 Jul 2026
Close
2.194000
Fair value
3.661058
Next-week expectancy
Negative 41.74%
Sharemaestro

AYJ Chart Pack

Valneva SE

Exchange
GER
Latest week
10 Jul 2026
Close
2.194000
Fair value
3.661058
Next-week expectancy
Negative 41.74%
Generated
16 Jul 2026 21:41
Sector
Healthcare
Industry
Biotechnology

Chart Summary

Over the latest 12 completed weeks ending 2026-07-10, AYJ fell 6.24%, moving from 2.34 to 2.19. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -40.90 and has softened across the 12-week window. Market Dynamics is -0.61 on the latest week. Next-week expectancy is negative at 41.74% based on similar historical setup states.

Key Points

Week Ending
10 Jul 2026
Latest Close
2.19
12-Week Change
-6.24%
Trend Signal
Inactive
Next-Week Expectancy
Negative 41.74%
Signal Weeks
0 of 12
Vs Trend Line
Below
Vs Fair Value
Below
Relative Strength
-40.90
Market Dynamics
-0.61

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
10 Jul 2026
Latest Close
2.19
12-Week Change
-6.24%
Trend Signal
Inactive
Next-Week Expectancy
Negative 41.74%
Signal Weeks
0 of 12
Vs Trend Line
Below
Vs Fair Value
Below
Relative Strength
-40.90
Market Dynamics
-0.61

Over the latest 12 completed weeks ending 2026-07-10, AYJ fell 6.24%, moving from 2.34 to 2.19. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -40.90 and has softened across the 12-week window. Market Dynamics is -0.61 on the latest week. Next-week expectancy is negative at 41.74% based on similar historical setup states.

Industry Peers

Germany equities in Biotechnology

Stock Exchange Week Open High Low Close Change
GE9 GENMAB AS N GER 10 Jul 2026 246.20 257.90 246.20 257.90 4.75%
HPHA Heidelberg Pharma AG GER 10 Jul 2026 2.56 2.79 2.56 2.66 3.91%
B72 AtaiBeckley Inc. GER 10 Jul 2026 4.46 4.72 4.24 4.60 3.14%
RGO Regeneron Pharmaceuticals, Inc. GER 10 Jul 2026 574.00 587.60 563.50 579.30 0.92%
BBZA BB Biotech AG GER 10 Jul 2026 33.40 33.40 33.40 33.40 0.00%
PSH0 Sernova Biotherapeutics Inc GER 10 Jul 2026 0.08 0.09 0.08 0.08 0.00%
FYB Formycon AG GER 10 Jul 2026 19.30 19.58 18.24 18.80 -2.59%
NP5 Newron Pharmaceuticals S.p.A. GER 10 Jul 2026 13.40 13.50 12.80 13.05 -2.61%
PTP Pentixapharm Holding AG N GER 10 Jul 2026 2.28 2.32 2.00 2.18 -4.39%
VX1 Vertex Pharmaceuticals Incorporated GER 10 Jul 2026 463.40 464.00 424.15 425.60 -8.16%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.